Loading...

APC anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-F11_APC_090507
C57BL/6 mouse splenocytes stained with 30-F11 APC
  • 30-F11_APC_090507
    C57BL/6 mouse splenocytes stained with 30-F11 APC
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
103111 25 µg 27€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103112 100 µg 76€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Gavin KM, et al. 2018. Front Endocrinol (Lausanne). 9:276. PubMed
  2. Wang L, et al. 2018. Bone Res. 6:22. PubMed
  3. Cha JH et al. 2018. Molecular cell. 71(4):606-620 . PubMed
  4. Haimon Z et al. 2018. Nature immunology. 19(6):636-644 . PubMed
  5. Ying W, et al. 2019. Cell Metab. 29:457. PubMed
  6. Witherel CE, et al. 2021. Biomaterials. 269:120667. PubMed
  7. Kozuki S, et al. 2022. Genes Cells. 27:192. PubMed
  8. Cautivo KM, et al. 2022. Immunity. 55:254. PubMed
  9. Liang X, et al. 2022. Cancer Commun (Lond). 42:205. PubMed
  10. Lloyd-Lewis B, et al. 2022. Cell Rep. 38:110461. PubMed
  11. Yang Y, et al. 2022. FEBS J. 289:5279. PubMed
  12. MacLean AJ, et al. 2022. Immunity. 55:718. PubMed
  13. Yousefi M, et al. 2022. Cancer Res. 82:1589. PubMed
  14. Van Deren DA, et al. 2022. Development. 149: . PubMed
  15. Lee R, et al. 2022. Cancer Discov. 12:1702. PubMed
  16. Jiang W, et al. 2022. FASEB J. 36:e22294. PubMed
  17. Wang S, et al. 2022. Sci Adv. 8:eabn3883. PubMed
  18. Wu TJ, et al. 2022. Cell Mol Life Sci. 79:348. PubMed
  19. Malhi H, et al. 2022. Cell Rep Med. 3:100658. PubMed
  20. Campisi L, et al. 2022. Nature. 606:945. PubMed
  21. Ma Z, et al. 2022. Theranostics. 12:4965. PubMed
  22. Richards M, et al. 2022. Elife. 11: . PubMed
  23. Gao Y, et al. 2022. Cell Res. 32:1086. PubMed
  24. Ge Y, et al. 2022. iScience. 25:105437. PubMed
  25. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  26. Cattaneo P, et al. 2022. Nat Commun. 13:7444. PubMed
  27. Wang H, et al. 2022. J Nanobiotechnology. 20:513. PubMed
  28. Kuo CS, et al. 2022. Elife. 11: . PubMed
  29. Ge Y, et al. 2022. STAR Protoc. 4:101936. PubMed
  30. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  31. Urata S, et al. 2023. Microbiol Immunol. 67:105. PubMed
  32. Al-Saafeen BH, et al. 2023. Front Immunol. 13:1017780. PubMed
  33. Hu R, et al. 2023. Cell Death Discov. 9:50. PubMed
  34. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  35. Dragan M, et al. 2022. J Invest Dermatol. 142:583. PubMed
  36. Wei J, et al. 2022. Cancer Prev Res (Phila). 15:285. PubMed
  37. Yang Z, et al. 2022. J Nucl Med. 63:1708. PubMed
  38. Xin DQ, et al. 2022. Neural Regen Res. 17:2238. PubMed
  39. Li DD, et al. 2022. Cell Host Microbe. 30:530. PubMed
  40. Bohrer AC, et al. 2022. Cell Rep. 40:111144. PubMed
  41. Yu L, et al. 2022. Cancer Sci. 113:3980. PubMed
  42. Kuo A, et al. 2022. Elife. 11:. PubMed
  43. Chen LC, et al. 2023. Immunology. 169:271. PubMed
  44. Wilson NG, et al. 2023. iScience. 26:105991. PubMed
  45. Peng YJ, et al. 2023. Development. 150:. PubMed
  46. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  47. Pioli KT, et al. 2023. iScience. 26:106223. PubMed
  48. Wu Y, et al. 2023. Nat Cancer. 4:382. PubMed
  49. Henn RE, et al. 2023. iScience. 26:106164. PubMed
  50. Barberio AE, et al. 2023. Bioeng Transl Med. 8:e10453. PubMed
  51. Kawai H, et al. 2023. JBMR Plus. 7:e10722. PubMed
  52. Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed
  53. Palakurthi B, et al. 2023. Nat Commun. 14:2109. PubMed
  54. Yao H, et al. 2023. Front Immunol. 14:1147674. PubMed
  55. Hernandez VG, et al. 2023. Glia. 71:1960. PubMed
  56. Liu H, et al. 2023. Breast Cancer Res. 25:43. PubMed
  57. Petenkova A, et al. 2023. Nat Commun. 14:2761. PubMed
  58. Abdelwahab T, et al. 2023. iScience. 26:106698. PubMed
  59. Shao X, et al. 2023. Cell Discov. 9:44. PubMed
  60. Vereertbrugghen A, et al. 2023. J Neuroinflammation. 20:120. PubMed
  61. Kalgudde Gopal S, et al. 2023. Nat Commun. 14:3020. PubMed
  62. Li M, et al. 2023. BMC Cancer. 23:497. PubMed
  63. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  64. Kuo PC, et al. 2021. Brain Commun. 3:fcab187. PubMed
  65. Nigam S, et al. 2020. Mol Imaging Biol. 22:685. PubMed
  66. Yang D, et al. 2022. Cell. 185:1905. PubMed
  67. Jiang Z, et al. 2021. J Clin Invest. 131: . PubMed
  68. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  69. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  70. Strickley JD, et al. 2019. Nature. 575:519. PubMed
  71. Oetjen LK et al. 2017. Cell. 171(1):217-228 . PubMed
  72. Testini C, et al. 2019. EMBO Rep. 20:e47845. PubMed
  73. Gao Q, et al. 2019. J Exp Med. 216:688. PubMed
  74. Shavit Stein E, et al. 2018. Neural Plast. 2018:7692182. PubMed
  75. Bouchareychas L, et al. 2021. iScience. 24(8):102847. PubMed
  76. Almada AE, et al. 2021. Cell Reports. 34(4):108656. PubMed
  77. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  78. Garcia-Fabiani MB, et al. 2020. Methods Enzymol. 632:369. PubMed
  79. Jaiswal AK, et al. 2020. Immunobiology. 225:151956. PubMed
  80. Cayre S, et al. 2020. Development. 147:00:00. PubMed
  81. Díaz NM, et al. 2020. Invest Ophthalmol Vis Sci. 61:37:00. PubMed
  82. Mourao L, et al. 2019. Sci Rep. 0.991666667. PubMed
  83. Karlen SJ, et al. 2018. J Neuroinflammation. 15:344. PubMed
  84. Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed
  85. Wang Y, et al. 2021. J Bone Oncol. 30:100386. PubMed
  86. Lu L, et al. 2022. Sci Rep. 12:931. PubMed
  87. Parhiz H, et al. 2022. J Control Release. 344:50. PubMed
  88. Yu K, et al. 2021. Cell Reports. 35(12):109273. PubMed
  89. Lim JT, et al. 2020. Mol Cancer Ther. 1809:19. PubMed
  90. Rosa FF, et al. 2020. Bio Protoc. 10:e3619. PubMed
  91. Ahmed M, et al. 2016. Development. 143: 1663 - 1673. PubMed
  92. Kang I, et al. 2012. Blood. 119:3295. PubMed
  93. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  94. Chen J, et al. 2022. Nat Commun. 13:6759. PubMed
  95. Wang S, et al. 2022. Front Immunol. 13:869061. PubMed
  96. Zhang Y, et al. 2022. Cancers (Basel). 14:. PubMed
  97. Barwe SP, et al. 2022. J Clin Med. 11:. PubMed
  98. Tilstam PV, et al. 2021. J Clin Invest. 131:. PubMed
  99. Yu X, et al. 2021. Nature. 594:560. PubMed
  100. Sato S, et al. 2021. Int J Mol Sci. 22:. PubMed
  101. Oliva Chávez AS, et al. 2021. Nat Commun. 12:3696. PubMed
  102. Yanagida K, et al. 2020. Dev Cell. 779:52. PubMed
  103. Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed
  104. Larouche JA, et al. 2021. eLife. 0.416666666666667. PubMed
  105. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  106. Barberio AE, et al. 2020. ACS Nano. 14:11238. PubMed
  107. Chiche A, et al. 2016. Oncogene. 10.1038/onc.2016.396. PubMed
  108. Eastman A, et al. 2016. J Immunol . 194: 5999-6010. PubMed
  109. Engelbrecht E, et al. 2020. eLife. 9:e52690.. PubMed
  110. Hays C, et al. 2020. eLife. 8:e48772.. PubMed
  111. Jin X, et al. 2019. Mol Cell. 73:22:00. PubMed
  112. Duarte N, et al. 2018. Hepatol Commun. 0.833333333. PubMed
  113. Romagnoli M, et al. 2020. Development. 147:. PubMed
  114. Li Q, et al. 2021. Brain Behav Immun. 94:437. PubMed
  115. Wang X, et al. 2022. Nat Aging. 2:155. PubMed
  116. Wang T, et al. 2020. Blood Sci. 2:79. PubMed
  117. Strunz M, et al. 2020. Nat Commun. 2.929861111. PubMed
  118. Shemer A, et al. 2020. Immunity. 53(5):1033-1049.e7. PubMed
  119. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
  120. Wosczyna MN, et al. 2021. Cell Stem Cell. 28(7):1323-1334.e8. PubMed
  121. Okuniewska M, et al. 2021. Cell Reports. 36(2):109368. PubMed
  122. Zhao B, et al. 2021. Cell Reports. 36(3):109401. PubMed
  123. Motoyama S, et al. 2020. Cells. :9. PubMed
  124. Park JA, et al. 2021. J Hematol Oncol. 14:142. PubMed
  125. Ning X, et al. 2019. Mol Cell. 74:19. PubMed
  126. De S, et al. 2018. Development. 145. PubMed
  127. Xiao X, et al. 2019. Cell Discov. 5:2. PubMed
  128. Mauduit O, et al. 2022. Front Immunol. 13:1011125. PubMed
  129. Chen Z, et al. 2022. Theranostics. 12:6242. PubMed
  130. Xu X, et al. 2021. J Nanobiotechnology. 19:376. PubMed
  131. Bourn JR, et al. 2021. Cancer Lett. 503:75. PubMed
  132. Khateb M, et al. 2022. Cell Rep. 40:111219. PubMed
  133. Xu Q, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  134. Liu K, et al. 2022. Theranostics. 12:639. PubMed
  135. Sato Y, et al. 2021. J Clin Invest. Online ahead of print. PubMed
  136. Lv H, et al. 2020. Cell Metabolism. 33(1):110-127.e5. PubMed
  137. Amouyal C, et al. 2020. EBioMedicine. 58:102895. PubMed
  138. Liu L, et al. 2015. Neurol Neuroimmunol Neuroinflamm. 2: 174. PubMed
  139. Hyatt L, et al. 2014. PLoS One. 9:109072. PubMed
  140. Pelletier A, et al. 2012. J Immunol. 188:5561. PubMed
  141. Herting CJ, et al. 2019. Brain. 142:3834. PubMed
  142. Romagnoli M, et al. 2019. Stem Cell Reports. 1.077083333. PubMed
  143. An J,et al. 2017. Sci Rep.. 10.1038/s41598-017-13629-0. PubMed
  144. Wosczyna MN et al. 2019. Cell Rep. 27(7):2029-2035 . PubMed
  145. Maston LD, et al. 2017. Am J Physiol Lung Cell Mol Physiol. 312:L609. PubMed
  146. Bresson L, et al. 2018. Development. 145. PubMed
  147. Charmsaz S, et al. 2017. Leukemia. 31:1779. PubMed
  148. Palathingal Bava E, et al. 2022. JCI Insight. 7:. PubMed
  149. Ma S, et al. 2021. Cell Reports. 34(6):108726. PubMed
  150. Ankawa R, et al. 2021. Developmental Cell. . PubMed
  151. Hu EY, et al. 2021. Blood Adv. 5:3152. PubMed
  152. Lafkas D, et al. 2013. J Cell Biol. 203:47. PubMed
  153. Sambasivan R, et al. 2011. Development. 138:3647. PubMed
  154. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  155. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  156. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  157. Zheng B, et al. 2018. J Hematol Oncol. 11:16. PubMed
  158. Pal B, et al. 2017. Nat Commun.. 10.1038/s41467-017-01560-x. PubMed
  159. Fischer A, et al. 2022. Nat Immunol. 23:518. PubMed
  160. Hu J, et al. 2022. Cell Mol Neurobiol. . PubMed
  161. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  162. Shcherbina A, et al. 2020. Cell Rep. 32:107964. PubMed
  163. Wu J, et al. 2020. Immunity. 53:115. PubMed
  164. Frii J, et al. 2021. Immunity. 54(5):1002-1021.e10. PubMed
  165. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  166. Kotfis K, et al. 2020. British Journal of Pharmacology. 49(1):66-72. PubMed
  167. Yuan Z, et al. 2018. Emerg Microbes Infect. 7:59. PubMed
  168. Pezoldt J, et al. 2022. Nat Commun. 13:7227. PubMed
  169. Hanasoge Somasundara AV, et al. 2021. Cell Rep. 37:110099. PubMed
  170. Thinard R, et al. 2022. Pharmaceutics. 14:. PubMed
  171. Yang H, et al. 2022. Nutrients. 14:. PubMed
  172. Hu J, et al. 2022. J Neuroinflammation. 19:71. PubMed
  173. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  174. Morimoto A, et al. 2021. Nat Commun. 12:2136. PubMed
  175. Hou M, et al. 2020. Stem Cell Res Ther. 11:55. PubMed
  176. Bradley KC, et al. 2019. Cell Rep. 28:245. PubMed
  177. Crooks SD, et al. 2022. Immunohorizons. 6:705. PubMed
  178. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  179. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  180. Koren E, et al. 2022. Nat Commun. 13:4628. PubMed
  181. Bauer T, et al. 2021. Life (Basel). 11:. PubMed
  182. Li P, et al. 2022. EMBO Mol Med. 14:e14511. PubMed
  183. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  184. Myerson JW, et al. 2021. Nat Nanotechnol. Online ahead of print. PubMed
  185. Jia Q, et al. 2021. Theranostics. 4699:11. PubMed
  186. Paiva-Oliveira E, et al. 2017. Histochem Cell Biol. 10.1007/s00418-017-1556-6. PubMed
  187. Dudek KA, et al. 2020. Proc Natl Acad Sci U S A. 117:3326. PubMed
  188. Scur M, et al. 2022. Nat Commun. 13:7272. PubMed
  189. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  190. Yang Y, et al. 2022. Elife. 11:. PubMed
  191. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  192. Zhang Q, et al. 2022. Nat Commun. 13:2406. PubMed
  193. Mizuno T, et al. 2017. Sci Rep. 7:42714. PubMed
  194. Nosho S, et al. 2020. Int J Mol Sci. 21:00. PubMed
  195. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  196. Wang C, et al. 2011. Hepatology. 55:108. PubMed
  197. Sim S, et al. 2016. PLoS One. 11: 0152485. PubMed
  198. Mangum L, et al. 2016. Toxicol Sci. 150: 169 - 177. PubMed
  199. Kaur A, et al. 2019. Cancer Discov. 9:64. PubMed
  200. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  201. Zhou G, et al. 2019. FASEB J. 33:11396. PubMed
  202. Tu WL, et al. 2018. Am J Pathol. 188:2688. PubMed
  203. Chiche A, et al. 2019. Breast Cancer Res. 21:13. PubMed
  204. Feng J,et al. 2017. Nat Commun. . 10.1038/s41467-017-01056-8. PubMed
  205. Limbad C, et al. 2022. iScience. 25:103848. PubMed
  206. Chiang HY, et al. 2022. Nat Commun. 13:874. PubMed
  207. Aguilera M, et al. 2021. Int J Mol Sci. 22:. PubMed
  208. Xi W, et al. 2021. Stem Cell Res Ther. 167:12. PubMed
  209. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  210. Dawson CA, et al. 2021. Nature Protocols. 16(4):1907-1935. PubMed
  211. Seki T, et al. 2015. J Biochem. 158: 485 - 495. PubMed
  212. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  213. Echevarría-Vargas IM, et al. 2018. EMBO Mol Med. 10:e8446. PubMed
  214. Shi R, et al. 2019. J Cancer. 10:367. PubMed
  215. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  216. Usmani SM et al. 2019. Cell host & microbe. 25(1):73-86 . PubMed
  217. Zasłona Z, et al. 2017. Am J Physiol Lung Cell Mol Physiol. 312:L855. PubMed
  218. Han Y, et al. 2022. Int J Biol Sci. 18:5653. PubMed
  219. Dion-Albert L, et al. 2022. Nat Commun. 13:164. PubMed
  220. Long JT, et al. 2022. Elife. 11:. PubMed
  221. Zhang Z, et al. 2021. Exp Dermatol. 30:102. PubMed
  222. Perry JL, et al. 2020. ACS Nano. 5.583333333. PubMed
  223. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  224. Penkert RR, et al. 2020. Obesity (Silver Spring). 1631:28. PubMed
  225. Mori A, et al. 2021. Cells. :10. PubMed
  226. Garcia-Bonilla L, et al. 2014. J Immunol. 193:2531. PubMed
  227. Ding X, et al. 2015. J Immunol. 194:4251. PubMed
  228. Wang L, et al. 2015. Cancer Immunol Res. 3: 1030-1041. PubMed
  229. Mueller A, et al. 2016. Nature. 540:276-279. PubMed
  230. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  231. Liu D, et al. 2020. Front Pharmacol. 11:204. PubMed
  232. Toyama K, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1392. PubMed
  233. Qiao S, et al. 2019. J Neuroinflammation. 16:4. PubMed
  234. Saber M, et al. 2021. J Neurosci Res. 99:1136. PubMed
  235. Takaku S, et al. 2022. Evid Based Complement Alternat Med. 2022:6122955. PubMed
  236. Murdock BJ, et al. 2021. JCI Insight. 6:. PubMed
  237. Yang Y, et al. 2021. Cell Reports. 34(10):108822. PubMed
  238. Taya M, et al. 2020. Endocr Relat Cancer. 27:261. PubMed
  239. Cai B, et al. 2020. Cell Metabolism. 31(2):406-421.e7.. PubMed
  240. Lu Y, et al. 2020. Immunity. 52:782. PubMed
  241. Carmody C et al. 2019. Endocrinology. 160(5):1205-1222 . PubMed
  242. Fu NY, et al. 2018. Dev Cell. 47:629. PubMed
  243. Hoover AR, et al. 2022. Clin Transl Med. 12:e937. PubMed
  244. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  245. Deng P, et al. 2021. Cell Stem Cell. 28(6):1057-1073.e7. PubMed
  246. Zhang Y, et al. 2020. Cancer Res. 80:3345. PubMed
  247. Elias S, et al. 2015. PLoS Biol. 13:1002142. PubMed
  248. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  249. Yeo SK, et al. 2020. eLife. 9:e58810.. PubMed
  250. Cao Y, et al. 2019. Nat Commun. 10:1280. PubMed
  251. Liu L et al. 2018. Cell stem cell. 23(4):544-556 . PubMed
  252. Zheng Y, et al. 2022. J Immunol. 208:501. PubMed
  253. Bagati A, et al. 2020. Cancer Cell. 39(1):54-67.e9. PubMed
  254. Nasser H, et al. 2020. Cell Death Discov. 0.29375. PubMed
  255. Sroor HM, et al. 2019. Sci Rep. 9:20217. PubMed
  256. Chen PY, et al. 2019. Nat Metab. 0.675. PubMed
  257. Porrello A, et al. 2018. Nat Commun. 9:1988. PubMed
  258. Kim KS, et al. 2022. JCI Insight. 7:. PubMed
  259. Cai T, et al. 2022. Nat Commun. 13:2228. PubMed
  260. Zhang T, et al. 2020. JCI Insight. 5:00. PubMed
  261. Ortiz A, et al. 2019. Cancer Cell. 35:33:00. PubMed
  262. Ouadah Y, et al. 2019. Cell. 179:403. PubMed
  263. Piotrowski AF, et al. 2018. Oncoimmunology. 7:e1445951. PubMed
  264. Sarshad AA, et al. 2018. Mol Cell. 71:1040. PubMed
  265. Gopalakrishnapillai A, et al. 2021. Cancers (Basel). 13:. PubMed
  266. Liu G, et al. 2022. Theranostics. 12:2248. PubMed
  267. Piirainen S, et al. 2021. Glia. 69:2459. PubMed
  268. Arora S, et al. 2021. Med (N Y). 2:938. PubMed
  269. Li H, et al. 2022. iScience. 25:104481. PubMed
  270. Cayre S, et al. 2020. Development. . PubMed
  271. Endo-Umeda K, et al. 2021. Sci Rep. 11:22595. PubMed
  272. Pal B, et al. 2021. Breast Cancer Res. 23:69. PubMed
  273. Maller O, et al. 2020. Nat Mater. 20:548. PubMed
  274. Saber M, et al. 2020. Eur J Neurosci. 52:2791. PubMed
  275. Vaas M, et al. 2016. J Cereb Blood Flow Metab. 10.1177/0271678X16676825. PubMed
  276. Wong J, et al. 2016. Sci Signal. 9: ra103. PubMed
  277. Yuan Z, et al. 2016. J Virol. 90: 7728 - 7739. PubMed
  278. Garcia-Bonilla L, et al. 2015. J Neurosci. 35: 14783 - 14793. PubMed
  279. Jiang Y, et al. 2015. MBio. 6: e01426-15. PubMed
  280. Roberts L, et al. 2014. Infect Immun . 82:2504. PubMed
  281. Su M, et al. 2018. Immunol Cell Biol. 9:2448. PubMed
  282. Wunderlich CM, et al. 2018. Nat Commun. 9:1646. PubMed
  283. Peltzer N, et al. 2018. Nature. 557:112. PubMed
  284. Hu Y, et al. 2021. J Nanobiotechnology. 19:416. PubMed
  285. Kastenschmidt JM, et al. 2021. Cell Rep. 35:108997. PubMed
  286. Jaeger N, et al. 2020. Cell Rep. 33:108331. PubMed
  287. Koh BI, et al. 2020. Nat Commun. 3.143055556. PubMed
  288. Ren D, et al. 2020. Am J Cancer Res. 2851:10. PubMed
  289. Qu Y, et al. 2020. Cell Reports. 32(1):107873. PubMed
  290. Kabir AU, et al. 2018. JCI Insight. 3. PubMed
  291. Quijano-Rubio A, et al. 2022. Nat Biotechnol. Online ahead of print. PubMed
  292. Scheyltjens I, et al. 2022. Nat Protoc. 17:2354. PubMed
  293. Liu C, et al. 2022. Nat Commun. 13:1989. PubMed
  294. Saber M, et al. 2021. J Neurotrauma. 38:2862. PubMed
  295. Wang Y, et al. 2022. Nat Cell Biol. 24:230. PubMed
  296. Okubo A, et al. 2021. Int J Mol Sci. 23:. PubMed
  297. Deets KA, et al. 2021. Elife. 10:. PubMed
  298. Murray CW, et al. 2022. Nat Commun. 13:1090. PubMed
  299. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  300. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
  301. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  302. Dai B, et al. 2021. Cell Reports Medicine. 2(8):100381. PubMed
  303. Bravo JI, et al. 2021. STAR Protocols. 2(2):100406. PubMed
  304. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
RRID
AB_312976 (BioLegend Cat. No. 103111)
AB_312977 (BioLegend Cat. No. 103112)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark Blue™ 515 anti-mouse CD45 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark PLUS UV395™ anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 30-F11 FC
Go To Top Version: 2    Revision Date: 05/14/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account